Anúncio
Anúncio
DARE
Dare Bioscience, Inc. Common Stock
1.99
USDPatrocinado
-0.08
-4.11%
09 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
2.01
+0.02
+1.26%
Relatórios de Lucros DARE
Rácio de surpresa positiva
DARE separação 23 de 36 últimas estimativas.
64%
Próximo Relatório
Data do Próximo Relatório
30 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$383.26K
/-$0.37
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+19063.25%
/+32.14%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
-698.85%
/-43.08%
Dare Bioscience, Inc. Common Stock earnings per share and revenue
On 13 de nov. de 2025, DARE reported earnings of -0.28 USD per share (EPS) for Q3 25, beating the estimate of -0.36 USD, resulting in a 23.03% surprise. Revenue reached 2.00 mil, compared to an expected 9.95 mil, with a -79.89% difference. The market reacted with a -1.59% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 analistas forecast an EPS of -0.37 USD, with revenue projected to reach 383.26 mil USD, implying an aumentar of 32.14% EPS, and aumentar of 19063.25% in Revenue from the last quarter.
FAQ
What were Dare Bioscience, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Dare Bioscience, Inc. Common Stock reported EPS of -$0.28, beating estimates by 23.03%, and revenue of $2.00K, -79.89% below expectations.
How did the market react to Dare Bioscience, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -1.59%, changed from $1.89 before the earnings release to $1.86 the day after.
When is Dare Bioscience, Inc. Common Stock expected to report next?
The next earning report is scheduled for 30 de mar. de 2026.
What are the forecasts for Dare Bioscience, Inc. Common Stock's next earnings report?
Based on 6
analistas, Dare Bioscience, Inc. Common Stock is expected to report EPS of -$0.37 and revenue of $383.26K for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio